This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Merck Sharp + Dohme Corp.. Active years: 2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2020
Title: The Innovations of David Thaisrivongs
Introduction
David Thaisrivongs is an accomplished inventor based in Cranford, NJ (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of inhibitors for critical enzymes. His work has the potential to impact the treatment of various diseases.
Latest Patents
David Thaisrivongs holds 1 patent for his invention titled "Processes for the preparation of a BACE inhibitor." This invention provides improved processes for the preparation of verubecestat, a potent inhibitor of BACE-1 and BACE-2. This advancement is crucial in the ongoing research for effective treatments in neurodegenerative diseases.
Career Highlights
Thaisrivongs is currently employed at Merck Sharp & Dohme Corp., a leading global healthcare company. His role involves extensive research and development, focusing on innovative solutions in drug formulation and delivery. His expertise in the field has positioned him as a valuable asset to his team.
Collaborations
Throughout his career, David has collaborated with notable colleagues, including William J. Morris and Thomas W. Lyons. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.
Conclusion
David Thaisrivongs exemplifies the spirit of innovation in the pharmaceutical industry. His contributions, particularly in the development of BACE inhibitors, highlight the importance of research in advancing medical science. His work continues to inspire future generations of inventors and researchers.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
